Modulation of Elevated Triglycerides and Mild NAFLD using Targeted Frequency Bioelectronic Therapy: A Case Study in a Young Healthy Male
Keywords:
chronic pain., biomarkers, opioid, opioid use disorder, neural alterations, Adults, Healthcare demand, Income inequalities, Propensity Score, Health Policy., mortality, admissions, emergency department., attendance, brought-in-deadAbstract
Triglycerides (TG), together with total cholesterol (Chol-T) as well as high and low- density lipoproteins (HDL, LDL), are lipids of fundamental importance for determining cardiovascular risk (Henein M.Y., 2023). TG are molecules composed of a glycerol nucleus and three fatty acids, fats that we can find in both animal and vegetable foods. They represent the main form of storage and transport of fatty acids within cells and in the plasma, while it is in the liver that the fundamental steps for the metabolism of fatty acids occur (Strable M.S, 2010). Levels of TG higher than 150 mg/dl fasting are characteristic of a state of dyslipidemia (Pappan N. et al., 2024), which can result from a hereditary condition or an incorrect lifestyle; however, this is a condition that, if left untreated, can over time lead to severe cardiovascular consequences or to non-alcoholic fatty liver disease (NAFLD) (Alves- Bezerra M., 2019). Currently, to normalize triglyceride levels in patients with dyslipidemia, fibrates (Spence J. D., 2020), statins, or statins and ezetimibide (Ferri N., 2023) are administrated. In minor forms of hypertriglyceridemia (HTG), the administration of supplements based on Omega-3 (Rodriguez D., 2022) or berberine (Osadnik T., 2022), silymarin (Li S. et al., 2024) in addition to the diet (Hyun Suk Lee, 2021) and physical exercise (Petridou A., 2022) are also accompained. Bioelectronic medicine (BEM) is increasingly expanding its field of research, today particularly oriented towards the modulation of the activity of the vagus nerve and its effects, for example, on the release of inflammatory cytokines (Borovikova et al., 2000); this innovative approach is increasingly moving towards new directions to the point of involving its effects on inflammatory, cardiovascular, neurodegenerative diseases (Pavlov A. P., 2022), urological disorders (Peregrine B.O., 2017), etc..
In this study, we wanted to verify the effectiveness of the BEM approach on human metabolism using a specific frequency indicated by the Grabovoj method (Grabovoj G., 2013) for the physiological regeneration of TG levels; we also wanted to verify the selectivity of the effects on the organism of the frequency used for the treatments, evaluating the variations in the levels of Chol-T, HDL, LDL and Glu at time zero and at the end of the work. From this assumption, we wanted to verify the response of a young, healthy male practising competitive sport characterized by non-physiological levels of TG (409 mg/dl) and a mild form of NAFLD by first treating him with berberine/silymarin/Omega-3 and an appropriate diet and then subjecting him to treatments with a specific frequency on the body applied via electrodes emitted by a BioLife-Regen frequency generator.
References
M. Alves-Bezerra, D.E. Cohen (2019) Triglyceride metabolism in the liver. 8(1), 1-8.
B. Bashir, J.H. Ho, et al. (2023) Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic Options. 13, 621.
K.E. Bornfeldt (2021) Triglyceride lowering by omega-3 fatty acids: a mechanism mediated by N-acyl taurines. 131(6).
L.V. Borovikova, S. Iavanova, et al. (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. 458-62.
A.C. Boullart, G.J. de GJ, A.F. Stalenhoef (2012) Serum triglycerides and risk of cardiovascular disease. 1821, 867e875.
M. Budoff (2016) Triglycerides and Triglyceride-Rich Lipoproteins in the Causal Pathway of Cardiovascular Disease. 138e145.
A. Carnicer-Lombarte, S.-T. Chen, G.G. Malliaras, D.G. Barone (2021) Foreign body reaction to implanted biomaterials and its impact in nerve neuroprosthetics. 9, 622524.
N. Chalasani, Z. Younossi, J.E. Lavine, A.M. Diehl, E.M. Brunt, K. Cusi, M. Charlton, A.J. Sanyal (2012) The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. 55, 2005–2023.
V. Chyzhyk, S. Kozmic, et al. (2019) Extreme hypertriglyceridemia: genetic diversity, pancreatitis, pregnancy, and prevalence. 13, 89–99.
F.E. Dewey, V. Gusarova, et al. (2017) Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease. 377, 211–221.
S.J. Dron, J. Wang, et al. (2019) Severe hypertriglyceridemia is primarily Polygenic. 13, 80–88.
N. Ferri, et al. (2023) Fixed combination for the treatment of Dyslipidaemia. 691–699.
J. Frey, J. Cagle, K.A. Johnson, J.K. Wong, J.D. Hilliard, C.R. Butson, et al. (2022) Past, present, and future of deep brain stimulation: hardware, software, imaging, physiology and novel approaches. 13.
Scott L. Friedman, B.A. Neuschwander-Tetri, M. Rinella, A.J. Sanyal (2018) Mechanisms of NAFLD development and therapeutic strategies. 24(7), 908-922.
G. Grabovoj (2013) Sequenze numeriche per rigenerare (e guarire) il tuo corpo. I.
X. Guo, X. Yin, Z. Liu, J. Wang (2022) Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment. 23, 15489.
R.A. Hegele, H.N. Ginsberg (2014) The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. 2, 655–666.
M.Y. Henein (2022) The role of inflammation in cardiovascular disease. 23, 12906.
Hyun Suk Lee, Junga Lee (2021) Effects of Combined Exercise and Low Carbohydrate Ketogenic Diet Interventions on Waist Circumference and Triglycerides in Overweight and Obese Individuals: A Systematic Review and Meta-Analysis. 18, 828.
A.D. Koutsouras, G.G. Malliaras, G. Langereis (2024) The rise of bioelectronic medicine.
U. Laufs, K.G. Parhofer, H. Scharnagl, W. Marz (2020) Clinical review on tryglicerides. 41, 99-109.
U. Laufs, H. Scharnagl, W. Marz (2015) Statin intolerance. 26(6).
S. Li, F. Duan, S. Li, B. Lu (2024) Administration of silymarin in NAFLD/NASH: a systematic review and meta-analysis. 29, 101174.
D.M. Mann, M. Woodward, P. Muntner, L. Falzon, I. Kronish (2010) Predictors of nonadherence to statins: a systematic review and meta-analysis. 44, 1410–1421.
M. Miller, N.J. Stone (2011) Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. 123, 2292e2333.
B.G. Nordestgaard, A. Varbo (2014) Triglycerides and cardiovascular disease. 384, 626–635.
T. Osadnik (2022) A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults. 183, 106402.
J. Oscarsson, E. Hurt-Camejo (2017) Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review. 16(1), 149.
N. Pappan, A.O. Awosika, A. Rehman (2024) Dyslipidemia. https://www.ncbi.nlm.nih.gov/books/NBK569371/
A.P. Pavlov, K.J. Tracey (2022) Bioelettronic medicine: preclinical insights and clinical advances. 110(21), 3627-3644.
B.O. Peregrine (2017) Stimulating bioelectronic medicine discovery for urological disorders. 313, F1133-F1135.
A. Petridou, V. Moungios (2022) Exercise to Lower Postprandial Lipemia: Why, When, What and How. 43, 1013–1022.
S.C. Pradhan, C. Girish (2006) Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. 124, 491–504.
K. Retterstol, I. Narverud (2017) Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics. 115.
D. Rodriguez (2022) Update on Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Health. 14, 5146.
G.C. Shearer (2012) Fish oil -- how does it reduce plasma triglycerides?. 1821(5), 843–851.
A.K. Singh, R. Awasthi, R. Malviya (2022) Bioelectronic medicines: Therapeutic potential and advancements in next-generation cancer therapy. 1877.
J.D. Spence (2020) Triglyceride lowering drugs: not just icosapent ethyl. 41(15), 1520.
M.S. Strable, J.M. Ntambi (2010) Genetic control of de novo lipogenesis: role in diet-induced obesity. 45(3).
E.S. Stroes, P.D. Thompson, A. Corsini, G.D. Vladutiu (2015) Statin-associated muscle symptoms: impact on statin therapy - European Atherosclerosis Society Consensus Panel Statement on Assessment. Aetiology and Management. 36, 1012–1022.
J. Truthmann, A. Schienkiewitz (2016) Changes in mean serum lipids among adults in Germany: results from National Health Surveys 1997-99 and 2008-11. 240.
K. Wadhwa, R. Pahwa (2022) Mechanistic insights into the pharmacological significance of sylimarin. 27, 5327.
L. Wang, H.I. Cong (2020) Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. 80.
G. Yuan, K.Z. Al-Shali, R.A. Hegele (2007) Hypertriglyceridemia: its etiology, effects and treatment. 176, 1113–20.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Authors and Global Journals Private Limited

This work is licensed under a Creative Commons Attribution 4.0 International License.
